Spring Bank Pharmaceuticals Inc. | Balance Sheet
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
6,301.00
1,570.00
9,682.00
24,730.00
50,555.00
47,638
Total Accounts Receivable
-
11,562.00
-
-
-
-
Other Current Assets
656.00
547.00
313.00
840.00
580.00
1,649
Total Current Assets
6,957.00
13,679.00
9,995.00
25,570.00
51,135.00
49,287
Net Property, Plant & Equipment
113.00
126.00
427.00
522.00
687.00
2,319
Total Investments and Advances
-
-
3,189.00
752.00
484.00
17,038
Other Assets
434.00
-
966.00
35.00
35.00
167
Total Assets
7,629.00
13,805.00
14,577.00
26,879.00
52,341.00
68,811
ST Debt & Current Portion LT Debt
3,616.00
-
-
-
-
Accounts Payable
369.00
348.00
2,183.00
1,519.00
1,700.00
Income Tax Payable
125.00
-
-
-
-
Other Current Liabilities
611.00
1,257.00
1,369.00
1,982.00
2,734.00
Total Current Liabilities
4,721.00
1,605.00
3,552.00
3,501.00
4,434.00
Deferred Taxes
125.00
-
-
-
-
Other Liabilities
-
-
-
6,360.00
13,159.00
Total Liabilities
4,721.00
1,605.00
3,552.00
9,861.00
17,593.00
Common Equity (Total)
2,908.00
12,200.00
11,025.00
17,018.00
34,748.00
Total Shareholders' Equity
2,908.00
12,200.00
11,025.00
17,018.00
34,748.00
Total Equity
2,908.00
12,200.00
11,025.00
17,018.00
34,748.00
Liabilities & Shareholders' Equity
7,629.00
13,805.00
14,577.00
26,879.00
52,341.00
About Spring Bank Pharmaceuticals
View Profile
